Home/Filings/4/0001600620-24-000019
4//SEC Filing

Robertson Stephen P. 4

Accession 0001600620-24-000019

CIK 0001600620other

Filed

Feb 21, 7:00 PM ET

Accepted

Feb 22, 4:29 PM ET

Size

5.1 KB

Accession

0001600620-24-000019

Insider Transaction Report

Form 4
Period: 2024-02-20
Robertson Stephen P.
EVP, General Counsel
Transactions
  • Award

    Common Stock

    2024-02-20+194,230501,569 total
Footnotes (2)
  • [F1]Represents grant of Restricted Stock Units (RSUs) payable solely in common stock of the Issuer that vest in three (3) equal annual installments on the first, second and third anniversary of the grant date.
  • [F2]Includes shares of common stock acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 2,500 shares of common stock were acquired on May 31, 2023 and 1,717 shares of common stock were acquired on November 30, 2023.

Issuer

Aurinia Pharmaceuticals Inc.

CIK 0001600620

Entity typeother

Related Parties

1
  • filerCIK 0001837798

Filing Metadata

Form type
4
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:29 PM ET
Size
5.1 KB